Filed: 8/13/2024ACC: 0001420506-24-001376
📋 What this filing means
STEMPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 42 equity positions with a total reported market value of $340.28M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
42
Positions
$340.28M
Total AUM (reported)
32.23M
Total Shares
Allocation by class
COM$219.31M64.5%
SHS$34.51M10.1%
COM NEW$22.95M6.7%
COMMON STOCK$19.47M5.7%
ADS$13.87M4.1%
SPONSORED ADR$9.47M2.8%
SPON ADS$9.27M2.7%
Portfolio Concentration
Top 3$84.38M24.8%
4–10$104.07M30.6%
11–25$101.86M29.9%
Rest$49.97M14.7%
Top 3 weight
24.8%
Top 10 weight
55.4%
Voting Authority Distribution
Total shares with voting rights: 32.23M
Sole
Full voting authority
29.12M
shares
% of voting shares90.4%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
3.10M
shares
% of voting shares9.6%
Investment Discretion (by position count)
Sole42
Shared0
Other0
Dominant voting typeSole · 90.4% of voting shares
Institutional Holdings42
Rows:
SYNDAX PHARMACEUTICALS INC
SOLEShares1.41M
TypeSH
Market value$28.99M
8.52%
Sole
1.21M
Shared
0.00
None
199.10K
ROIVANT SCIENCES LTD
SOLEShares2.71M
TypeSH
Market value$28.67M
8.43%
Sole
2.71M
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares1.01M
TypeSH
Market value$26.71M
7.85%
Sole
805.45K
Shared
0.00
None
206.43K
CRINETICS PHARMACEUTICALS IN
SOLEShares551.10K
TypeSH
Market value$24.68M
7.25%
Sole
478.53K
Shared
0.00
None
72.56K
MERUS N V
SOLEShares288.67K
TypeSH
Market value$17.08M
5.02%
Sole
288.67K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares280.71K
TypeSH
Market value$15.49M
4.55%
Sole
280.71K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$14.83M
4.36%
Sole
1.28M
Shared
0.00
None
210.34K
IMMUNOCORE HLDGS PLC
SOLEShares339.35K
TypeSH
Market value$11.50M
3.38%
Sole
241.21K
Shared
0.00
None
98.15K
APPLIED THERAPEUTICS INC
SOLEShares2.21M
TypeSH
Market value$10.33M
3.03%
Sole
1.80M
Shared
0.00
None
411.97K
MERCK & CO INC
SOLEShares81.51K
TypeSH
Market value$10.15M
2.98%
Sole
81.51K
Shared
0.00
None
0.00
GSK PLC
SOLEShares245.93K
TypeSH
Market value$9.47M
2.78%
Sole
245.93K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares5.97M
TypeSH
Market value$9.33M
2.74%
Sole
5.97M
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
SOLEShares2.66M
TypeSH
Market value$9.27M
2.72%
Sole
2.02M
Shared
0.00
None
643.50K
CABALETTA BIO INC
SOLEShares1.18M
TypeSH
Market value$8.81M
2.59%
Sole
946.68K
Shared
0.00
None
231.43K
KALVISTA PHARMACEUTICALS INC
SOLEShares736.76K
TypeSH
Market value$8.68M
2.55%
Sole
622.22K
Shared
0.00
None
114.55K
BIOHAVEN LTD
SOLEShares233.25K
TypeSH
Market value$8.10M
2.38%
Sole
209.85K
Shared
0.00
None
23.40K
VISTAGEN THERAPEUTICS INC
SOLEShares1.85M
TypeSH
Market value$5.85M
1.72%
Sole
1.85M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares502.21K
TypeSH
Market value$5.84M
1.71%
Sole
502.21K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares251.01K
TypeSH
Market value$5.83M
1.71%
Sole
251.01K
Shared
0.00
None
0.00
INSMED INC
SOLEShares86.98K
TypeSH
Market value$5.83M
1.71%
Sole
86.98K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC NEW
SOLEShares144.47K
TypeSH
Market value$5.35M
1.57%
Sole
144.47K
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
SOLEShares704.35K
TypeSH
Market value$5.11M
1.50%
Sole
616.73K
Shared
0.00
None
87.62K
TSCAN THERAPEUTICS INC
SOLEShares845.07K
TypeSH
Market value$4.94M
1.45%
Sole
702.17K
Shared
0.00
None
142.90K
EDGEWISE THERAPEUTICS INC
SOLEShares271.06K
TypeSH
Market value$4.88M
1.43%
Sole
271.06K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares101.48K
TypeSH
Market value$4.59M
1.35%
Sole
82.36K
Shared
0.00
None
19.12K
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.41M | SH | $28.99M 8.52% | 1.21M | 0.00 | 199.10K |
ROIVANT SCIENCES LTDSOLE | SHS | 2.71M | SH | $28.67M 8.43% | 2.71M | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 1.01M | SH | $26.71M 7.85% | 805.45K | 0.00 | 206.43K |
CRINETICS PHARMACEUTICALS INSOLE | COM | 551.10K | SH | $24.68M 7.25% | 478.53K | 0.00 | 72.56K |
MERUS N VSOLE | COM | 288.67K | SH | $17.08M 5.02% | 288.67K | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 280.71K | SH | $15.49M 4.55% | 280.71K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.50M | SH | $14.83M 4.36% | 1.28M | 0.00 | 210.34K |
IMMUNOCORE HLDGS PLCSOLE | ADS | 339.35K | SH | $11.50M 3.38% | 241.21K | 0.00 | 98.15K |
APPLIED THERAPEUTICS INCSOLE | COM | 2.21M | SH | $10.33M 3.03% | 1.80M | 0.00 | 411.97K |
MERCK & CO INCSOLE | COM | 81.51K | SH | $10.15M 2.98% | 81.51K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 245.93K | SH | $9.47M 2.78% | 245.93K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | COM | 5.97M | SH | $9.33M 2.74% | 5.97M | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCSOLE | SPON ADS | 2.66M | SH | $9.27M 2.72% | 2.02M | 0.00 | 643.50K |
CABALETTA BIO INCSOLE | COM | 1.18M | SH | $8.81M 2.59% | 946.68K | 0.00 | 231.43K |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 736.76K | SH | $8.68M 2.55% | 622.22K | 0.00 | 114.55K |
BIOHAVEN LTDSOLE | COM | 233.25K | SH | $8.10M 2.38% | 209.85K | 0.00 | 23.40K |
VISTAGEN THERAPEUTICS INCSOLE | COM | 1.85M | SH | $5.85M 1.72% | 1.85M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 502.21K | SH | $5.84M 1.71% | 502.21K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 251.01K | SH | $5.83M 1.71% | 251.01K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 86.98K | SH | $5.83M 1.71% | 86.98K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INC NEWSOLE | COM NEW | 144.47K | SH | $5.35M 1.57% | 144.47K | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCSOLE | COM | 704.35K | SH | $5.11M 1.50% | 616.73K | 0.00 | 87.62K |
TSCAN THERAPEUTICS INCSOLE | COM | 845.07K | SH | $4.94M 1.45% | 702.17K | 0.00 | 142.90K |
EDGEWISE THERAPEUTICS INCSOLE | COM | 271.06K | SH | $4.88M 1.43% | 271.06K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 101.48K | SH | $4.59M 1.35% | 82.36K | 0.00 | 19.12K |
Page 1 of 2